These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6133496)

  • 1. Bacterial fimbriae as vaccines.
    Korhonen TK; Rhen M
    Ann Clin Res; 1982 Dec; 14(5-6):272-7. PubMed ID: 6133496
    [No Abstract]   [Full Text] [Related]  

  • 2. The molecular basis for the localization of bacterial infections.
    Christensen GD; Beachey EH
    Adv Intern Med; 1984; 30():79-112. PubMed ID: 6152109
    [No Abstract]   [Full Text] [Related]  

  • 3. Carboxymethyl high amylose starch for F4 fimbriae gastro-resistant oral formulation.
    Calinescu C; Nadeau E; Mulhbacher J; Fairbrother JM; Mateescu MA
    Int J Pharm; 2007 Oct; 343(1-2):18-25. PubMed ID: 17537598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New vaccines for travelers].
    Haditsch M
    Wien Klin Wochenschr; 2005; 117 Suppl 4():6-10. PubMed ID: 16416379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New vaccination strategies].
    Plotkin SA
    Bull Acad Natl Med; 2008 Mar; 192(3):511-8; discussion 518-9. PubMed ID: 18819697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Issues related to vaccinations in the European Union].
    Slusarczyk J
    Przegl Epidemiol; 2003; 57 Suppl 1():5-8. PubMed ID: 12920998
    [No Abstract]   [Full Text] [Related]  

  • 7. Infectious bovine keratoconjunctivitis: enhancement of Moraxella bovis pili immunogenicity with diphtheria-tetanus toxoids and pertussis vaccine.
    Pugh GW; Kopecky KE; McDonald TJ
    Am J Vet Res; 1984 Apr; 45(4):661-5. PubMed ID: 6145379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The polymeric stability of the Escherichia coli F4 (K88) fimbriae enhances its mucosal immunogenicity following oral immunization.
    Verdonck F; Joensuu JJ; Stuyven E; De Meyer J; Muilu M; Pirhonen M; Goddeeris BM; Mast J; Niklander-Teeri V; Cox E
    Vaccine; 2008 Oct; 26(45):5728-35. PubMed ID: 18762221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The chaperone-usher pathway of bacterial adhesin biogenesis -- from molecular mechanism to strategies of anti-bacterial prevention and modern vaccine design.
    Piatek R; Zalewska B; Bury K; Kur J
    Acta Biochim Pol; 2005; 52(3):639-46. PubMed ID: 16175239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of immune responses and prevention of alveolar bone loss by intranasal administration of mice with Porphyromonas gingivalis fimbriae and recombinant cholera toxin B subunit.
    Takahashi Y; Kumada H; Hamada N; Haishima Y; Ozono S; Isaka M; Yasuda Y; Tochikubo K; Umemoto T
    Oral Microbiol Immunol; 2007 Dec; 22(6):374-80. PubMed ID: 17949339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an enteric-coated pellet formulation of F4 fimbriae for oral vaccination of suckling piglets against enterotoxigenic Escherichia coli infections.
    Huyghebaert N; Snoeck V; Vermeire A; Cox E; Goddeeris BM; Remon JP
    Eur J Pharm Biopharm; 2005 Feb; 59(2):273-81. PubMed ID: 15661499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli F4 fimbriae specific llama single-domain antibody fragments effectively inhibit bacterial adhesion in vitro but poorly protect against diarrhoea.
    Harmsen MM; van Solt CB; Hoogendoorn A; van Zijderveld FG; Niewold TA; van der Meulen J
    Vet Microbiol; 2005 Nov; 111(1-2):89-98. PubMed ID: 16221532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current developments in new vaccines for adolescents.
    Rappuoli R
    Biologicals; 1997 Jun; 25(2):159-63. PubMed ID: 9236045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [DNA vaccines].
    Hovi T; Hyypiä T
    Duodecim; 1996; 112(18):1617-9. PubMed ID: 10596154
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaccines for fish in aquaculture.
    Sommerset I; Krossøy B; Biering E; Frost P
    Expert Rev Vaccines; 2005 Feb; 4(1):89-101. PubMed ID: 15757476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials.
    Clark JR; March JB
    Trends Biotechnol; 2006 May; 24(5):212-8. PubMed ID: 16567009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salmonella-based vaccines for infectious diseases.
    Kwon YM; Cox MM; Calhoun LN
    Expert Rev Vaccines; 2007 Apr; 6(2):147-52. PubMed ID: 17408365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming of piglets against enterotoxigenic E. coli F4 fimbriae by immunisation with FAEG DNA.
    Verfaillie T; Melkebeek V; Snoek V; Douterlungne S; Cox E; Verdonck F; Vanrompay D; Goddeeris B; Cox E
    Vaccine; 2004 Apr; 22(13-14):1640-7. PubMed ID: 15068846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-based approaches to develop vaccines against bacterial pathogens.
    Serruto D; Serino L; Masignani V; Pizza M
    Vaccine; 2009 May; 27(25-26):3245-50. PubMed ID: 19200820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyelonephritic Escherichia coli expressing P fimbriae decrease immune response of the mouse kidney.
    Rice JC; Peng T; Spence JS; Wang HQ; Goldblum RM; Corthésy B; Nowicki BJ
    J Am Soc Nephrol; 2005 Dec; 16(12):3583-91. PubMed ID: 16236807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.